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Immune mediated pathways are now recognized to play
a significant role in many common pathologies. The
immune system comprises a complex series of interactions
between cellular and molecular networks. The complexity
arises mainly from the requirement to offer host defence
against an almost infinite microbial pathogenic attach,
together with a requirement to regulate matters such that
host tissue damage is uncommon or at least limited. Fail-
ure of these complex regulatory pathways often leads to
induction or amplification of pathology. Using rheumatoid
arthritis as an exemplar, this lecture will consider the
opportunities available for clinical intervention now arising
as the molecular regulatory pathways in immune
responses are unraveled. The clinical success of biologic
agents that target cytokines e.g. tumour necrosis factor
and interleukin-6 receptor provide definitive proof of con-
cept that there are tractable checkpoints in the immune
network. In future, as more information emerges as to
how the immune system is organized in health and dis-
ease, it will become possible to intervene with greater dis-
cretion eventually to allow the re establishment of
immune homeostasis – that is the creation of immune tol-
erance. Such approaches offer the prospects for inflamma-
tory disease anticipation, abrogation and even prevention.
The potential for cellular modulatory pathways will be
explored in novel models of breach of tolerance. Similarly
new approaches to molecular complexity in the synovium
in particularly concerning microRNAs will be described.
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